Product
Monoclonal antibody anti-CGRP
1 clinical trial
1 indication
Indication
MigraineClinical trial
Prediction Study or Response to Treatment With Anti-CGRP Monoclonal Antibodies in MigraineStatus: Recruiting, Estimated PCD: 2025-06-01
1 clinical trial
1 indication